Battery pack management strategy in a hybrid electric motor vehicle

Details for Australian Patent Application No. 2009228332 (hide)

Owner International Truck Intellectual Property Company, LLC

Inventors Miller, Stanton E.

Agent Watermark

Pub. Number AU-B-2009228332

PCT Pub. Number WO2009/120740

Priority 12/054,542 25.03.08 US

Filing date 25 March 2009

Wipo publication date 1 October 2009

Acceptance publication date 19 January 2012

International Classifications

B60W 20/00 (2006.01) Control systems specially adapted for hybrid vehicles, i.e. vehicles having two or more prime movers of more than one type, e.g. electrical and internal combustion motors, all used for propulsion of the vehicle

B60K 6/28 (2007.10) Arrangement or mounting of plural diverse prime-movers for mutual or common propulsion, e.g. hybrid propulsion systems comprising electric motors and internal combustion engines

B60W 10/08 (2006.01) Conjoint control of vehicle sub-units of different type or different function - including control of electric propulsion units, e.g. motors or generators

B60W 10/26 (2006.01) Conjoint control of vehicle sub-units of different type or different function - for electrical energy, e.g. batteries or capacitors

Event Publications

23 September 2010 PCT application entered the National Phase

  PCT publication WO2009/120740 Priority application(s): WO2009/120740

19 January 2012 Application Accepted

  Published as AU-B-2009228332

17 May 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009228337-Compounds for the treatment of hepatitis C

2009228325-Pyrrolidine fused indolobenzadiazepine HCV NS5B inhibitors